deltatrials
Completed PHASE4 NCT00162357

Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty

Cardiolite-406; A Phase IV Open-Label, Randomized, Multi-Center Trial To Evaluate The Ability of Cardiolite Stress MPI to Detect Asymptomatic Restenosis in Diabetic Patients Who Have Undergone Percutaneous Coronary Intervention

Sponsor: Lantheus Medical Imaging

Conditions Coronary Restenosis Diabetes Mellitus, Type 2
Interventions Technetium Tc99m Sestamibi
Updated 6 times since 2017 Last updated: Apr 14, 2011 Started: Apr 30, 2004 Primary completion: Dec 31, 2005 Completion: Dec 31, 2005

This PHASE4 trial investigates Coronary Restenosis and Diabetes Mellitus, Type 2 and is currently completed. Lantheus Medical Imaging leads this study, which shows 6 recorded versions since 2004 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Apr 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Lantheus Medical Imaging
Data source: Lantheus Medical Imaging

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Burlington, United States
  • • Grand Rapids, United States
  • • Hartford, United States
  • • Roanoke, United States
  • • Roslyn, United States
  • • San Juan, Puerto Rico
  • • Waterbury, United States
  • • Wausau, United States